Uniphar (LON:UPR) Reaches New 52-Week High – Still a Buy?

Uniphar plc (LON:UPR) reached a new 52-week high during trading on Thursday . The company traded as high as GBX 240 ($3.18) and last traded at GBX 233 ($3.08), with a volume of 24164 shares trading hands. The stock had previously closed at GBX 230 ($3.04).

Wall Street Analyst Weigh In

Separately, Shore Capital reiterated a “buy” rating on shares of Uniphar in a research report on Tuesday, February 25th.

Uniphar Stock Up 1.3 %

The company has a current ratio of 0.90, a quick ratio of 0.60 and a debt-to-equity ratio of 119.48. The stock’s 50 day simple moving average is GBX 219.66 and its 200 day simple moving average is GBX 197.57. The stock has a market capitalization of £725.29 million, a P/E ratio of 16.20 and a beta of 0.75.

Uniphar Increases Dividend

The company also recently announced a dividend, which will be paid on Friday, May 16th. Investors of record on Thursday, April 24th will be paid a dividend of €0.01 ($0.01) per share. The ex-dividend date is Thursday, April 24th. This represents a yield of 0.47%. This is a boost from Uniphar’s previous dividend of $0.01. Uniphar’s dividend payout ratio (DPR) is currently 13.91%.

About Uniphar

Headquartered in Dublin, Ireland Uniphar plc is a diversified healthcare services business servicing the requirements of more than 200 multinational pharmaceutical and medical technology
manufacturers across three divisions – Commercial & Clinical, Product Access and Supply Chain & Retail. With a workforce of more than 2,000, the Group is active in Ireland, the UK and the Benelux.